New Models: Reinventing the Clinical Trial
Alphabet’s healthcare and life sciences arm is using data and machine learning to try and reinvent the famously difficult and inefficient clinical trial process.
Scarlet Shore, Head of Product and Project Baseline platform lead, Verily
What’s Next: Deals and IPOs
What companies are candidates for acquisition? Which unicorns will go public? Where will private money flow? Let’s find out.
Peter Orszag, CEO Financial Advisory and Fmr Global Co-Head of Health Care, Lazard Ltd
Jorge Conde, General Partner, Andreessen Horowitz
Ali Satvat, Private Equity Member, KKR
Moderator: David Faber, “Squawk on the Street” Co-anchor, CNBC
Genetics, CRISPR and Medical Ethics
Genomic medicine’s progress and future potential is hugely exciting, but it comes with enormous ethical implications. So how can we ensure its responsible use?
Paul Dabrowski, CEO, Synthego
Dr. William Hurlbut, Adjunct Professor, Senior Research Scholar in Neurobiology, Stanford Medical School; Distinguished Fellow, The Center for Bioethics and Human Dignity
Dr. Samarth Kulkarni, CEO, CRISPR Therapeutics
Moderator: Meg Tirrell, Biotech and pharma reporter, CNBC
Transformation: Data, A.I. and Health Care
The global health care market is among the AI industry’s fastest-growing subsectors. Find out how companies in this space are using big data analysis and AI to reinvent drug development, diagnostics and delivery.
Daphne Koller, Founder and CEO, insitro
Peter Lee, Corporate Vice President, Microsoft Healthcare
Dr. Jennifer Schneider, President, Livongo
James Park, Co-founder President and CEO, Fitbit
Moderator: Christina Farr, Technology and Health Reporter, CNBC.com
The Patient View: Courage and Purpose
When Biogen and its partner Eisai announced they were halting their clinical trial for Alzheimer’s, Jeff Borghoff, a patient in the failed drug trial, was devastated. But he isn’t giving up. Determined to find a treatment, he is exploring other possibilities. Here he shares important insights on the patient experience.
Presentation: Jeff Borghoff, Software Designer and Biogen Alzheimer’s Trial Participant
Interviewer: Sharon Epperson, Senior personal finance correspondent, CNBC
Defining the Future of US Health Care
Groundbreaking technology, backbreaking costs, policy battles, incredible cures. A panel of leading health care influencers discuss what they see coming next.
Dr. Ashish Jha, Global Health Initiative Director, Harvard T.H. Chan School of Public Health
Bob Sheehy, Co-founder and CEO, Bright Health; Fmr CEO, UnitedHealthcare
Andy Slavitt, General Partner, Town Hall Ventures; Fmr Commissioner, Centers for Medicare and Medicaid Services
Moderator: Bertha Coombs, Reporter, CNBC
The View from New Brunswick
Johnson & Johnson is continuously pioneering new techniques and concepts for a brighter, healthier future. What the landscape looks like from atop one of the world’s biggest and most admired health care companies.
Alex Gorsky, Chairman and CEO, Johnson & Johnson
Interviewer: Meg Tirrell, Biotech and pharma reporter, CNBC